Clonal hematopoiesis is associated with increased risk of ICANS in DLBCL patients with CAR-T cell therapy.
收藏NIAID Data Ecosystem2026-03-13 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA832976
下载链接
链接失效反馈官方服务：
资源简介：
Our study reveals that clonal hematopoiesis mutations, especially those associated with inflammation (DNMT3A, TET2, ASXL1), are associated with severe-grade neurotoxicities in lymphoma patients receiving anti-CD19 chimeric antigen receptortherapy. Further studies to investigate the mechanisms and interventions to improve toxicities in the context of CH are warranted.
创建时间：
2022-04-28
